DJIA 16,643.01 -11.76 -0.07%
NASDAQ 4,828.33 15.62 0.32%
S&P 500 1,988.87 1.21 0.06%
market minute promo

GlaxoSmithKline (NYSE: GSK)

company name or ticker
Company Photos
(Click to zoom)

Premarket Biotech Digest: Arrowhead Initiates Dosing, Vertex Orkambi Approval, Insider Sales

Week In Review: Zhongheng Pays $52 Million For Oramed's Diabetes Drugs

GlaxoSmithKline: An Undervalued 'Work In Progress'

Sector's Smaller Players Show The Way

PSA: Afrezza Is NOT Exubera

Premarket Biotech Digest: Gilead Files TAF NDA, Pristiq Goes Generic, Biocept Surges 7%

Premarket Biotech Digest: Celgene-Juno, AbbVie Rx Data, FDA-Gilead Lawsuit

Best 3 Yielding Buy-Rated Stocks: VLY, LHO, GSK

3 Reasons I Have Little Confidence in GlaxoSmithKline's Dividend

GlaxoSmithKline is yielding nearly 6% on a trailing 12-month basis, but these three factors have the potential to dramatically cut its payout in the coming years.

Wall Street is Betting Big Against These 3 Biotechs

Biotech stocks have had a huge run recently, and now Wall Street is betting heavily against these 3 recent winners.